MannKind

-$0.18 (-4.05%) Today
-$0.03 (-0.70%) As of 8:42 AM UTC after-hours

Why Robinhood?

You can buy or sell MannKind and other stocks, options, and ETFs commission-free!

About MNKD

MannKind Corp. operates as a biopharmaceutical company. It focuses on the discovery, development and commercialization of therapeutic products for diseases, such as diabetes and cancer.

CEO
Michael E. Castagna
Employees
241
Headquarters
Westlake Village, California
Founded
1991

MNKD Key Statistics

Market Cap
1.06B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
3.89M
High Today
$4.46
Low Today
$4.23
Open Price
$4.39
Volume
4.53M
52 Week High
$6.25
52 Week Low
$1.52

MNKD News

MarketWatchJun 16

MannKind Shares Rise 9% After Priority Review for Tyvaso DPI NDA

By Chris Wack MannKind Corp. shares were up 9% to $4.47 Wednesday after the U.S. Food and Drug Administration accepted for priority review the new drug applica

MNKD Earnings

-$0.08
-$0.05
-$0.03
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 4, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure